BALTIMORE--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR) will report its financial results for the third quarter ended September 30, 2006, after the close of trading on the NASDAQ Global Market on Thursday November 2, 2006. C. Randal Mills, Ph.D., President and Chief Executive Officer, and Cary J. Claiborne, Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Friday, November 3, 2006, at 8:30 a.m. EST. To access the live webcast, please log on to the Investor Relations section of the company's website at http://investor.osiris.com/events.cfm. Alternatively, callers may participate in the conference call by dialing 800-810-0924 (U.S. participants) or 913-981-4900 (international participants).
